Drug intelligence / Profile preview

metronidazole + miconazole nitrate

Development stage
Phase 2
Lead developer
Ambee Pharmaceuticals
Modality
Small Molecules
Administration
Vaginal
01

Overview

Ametrol-VT is a fixed-dose combination vaginal tablet containing metronidazole (100 mg) and miconazole nitrate (100 mg). Developed by Ambee Pharmaceuticals, it is approved for the local treatment of mixed vaginal infections, including bacterial vaginosis, trichomoniasis, and vulvovaginal candidiasis. Metronidazole acts as an antibacterial and antiprotozoal agent; upon intracellular reduction in anaerobic environments, it forms reactive intermediates that bind to and disrupt microbial DNA, leading to cell death. Miconazole nitrate is an imidazole antifungal that inhibits the enzyme lanosterol 14-alpha-demethylase, thereby blocking the synthesis of ergosterol, an essential component of the fungal cell membrane. Together, these components provide broad-spectrum coverage against co-existing bacterial, protozoal, and fungal pathogens in the vaginal tract.

Brand names
Ametrol-VT
Other names
Metronidazole + Miconazole Nitrate
02

Targets

CYP51A1 (Sterol 14α-demethylase)NeuraminidaseDNA

Beyond the preview

Go deeper on metronidazole + miconazole nitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metronidazole + miconazole nitrate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call